4D Molecular Therapeutics Statistics
Total Valuation
FDMT has a market cap or net worth of $755.19 million. The enterprise value is $363.78 million.
| Market Cap | 755.19M |
| Enterprise Value | 363.78M |
Important Dates
The next estimated earnings date is Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FDMT has 55.24 million shares outstanding. The number of shares has increased by 15.93% in one year.
| Current Share Class | 55.24M |
| Shares Outstanding | 55.24M |
| Shares Change (YoY) | +15.93% |
| Shares Change (QoQ) | +3.24% |
| Owned by Insiders (%) | 2.84% |
| Owned by Institutions (%) | 86.16% |
| Float | 42.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.21 |
| Forward PS | 50.91 |
| PB Ratio | 1.85 |
| P/TBV Ratio | 1.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.03, with a Debt / Equity ratio of 0.10.
| Current Ratio | 8.03 |
| Quick Ratio | 7.68 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -43.25% and return on invested capital (ROIC) is -27.21%.
| Return on Equity (ROE) | -43.25% |
| Return on Assets (ROA) | -25.09% |
| Return on Invested Capital (ROIC) | -27.21% |
| Return on Capital Employed (ROCE) | -43.58% |
| Weighted Average Cost of Capital (WACC) | 18.35% |
| Revenue Per Employee | $469,429 |
| Profits Per Employee | -$914,158 |
| Employee Count | 196 |
| Asset Turnover | 0.19 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +56.59% in the last 52 weeks. The beta is 2.74, so FDMT's price volatility has been higher than the market average.
| Beta (5Y) | 2.74 |
| 52-Week Price Change | +56.59% |
| 50-Day Moving Average | 13.41 |
| 200-Day Moving Average | 10.44 |
| Relative Strength Index (RSI) | 44.35 |
| Average Volume (20 Days) | 953,279 |
Short Selling Information
The latest short interest is 12.01 million, so 21.74% of the outstanding shares have been sold short.
| Short Interest | 12.01M |
| Short Previous Month | 12.07M |
| Short % of Shares Out | 21.74% |
| Short % of Float | 28.26% |
| Short Ratio (days to cover) | 10.88 |
Income Statement
In the last 12 months, FDMT had revenue of $92.01 million and -$179.18 million in losses. Loss per share was -$2.77.
| Revenue | 92.01M |
| Gross Profit | -145.10M |
| Operating Income | -193.92M |
| Pretax Income | -179.18M |
| Net Income | -179.18M |
| EBITDA | -188.89M |
| EBIT | -193.92M |
| Loss Per Share | -$2.77 |
Balance Sheet
The company has $361.33 million in cash and $39.22 million in debt, with a net cash position of $391.41 million or $7.09 per share.
| Cash & Cash Equivalents | 361.33M |
| Total Debt | 39.22M |
| Net Cash | 391.41M |
| Net Cash Per Share | $7.09 |
| Equity (Book Value) | 407.66M |
| Book Value Per Share | 7.38 |
| Working Capital | 335.28M |
Cash Flow
In the last 12 months, operating cash flow was -$156.07 million and capital expenditures $106,000, giving a free cash flow of -$155.97 million.
| Operating Cash Flow | -156.07M |
| Capital Expenditures | 106,000 |
| Depreciation & Amortization | 5.03M |
| Net Borrowing | 19.26M |
| Free Cash Flow | -155.97M |
| FCF Per Share | -$2.82 |
Margins
Gross margin is -157.70%, with operating and profit margins of -210.76% and -194.74%.
| Gross Margin | -157.70% |
| Operating Margin | -210.76% |
| Pretax Margin | -194.74% |
| Profit Margin | -194.74% |
| EBITDA Margin | -205.30% |
| EBIT Margin | -210.76% |
| FCF Margin | n/a |
Dividends & Yields
FDMT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -15.93% |
| Shareholder Yield | -15.93% |
| Earnings Yield | -23.73% |
| FCF Yield | -20.65% |
Analyst Forecast
The average price target for FDMT is $28.18, which is 106.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.18 |
| Price Target Difference | 106.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | -16.16% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FDMT has an Altman Z-Score of 0.4 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.4 |
| Piotroski F-Score | 2 |